Doctors are warning that Robert F. Kennedy Jr., Donald Trump’s nominee to Health and Human Services Secretary, is talking inaccurately about drugs like Ozempic and other similar medications used for treating obesity and diabetes.
In October, Kennedy appeared on Fox News’s Gutfeld! talk show, where he was asked about a study suggesting Ozempic might show promising addressing conditions including drug abuse, sleep apnea, and cognitive decline.